Valneva travel vaccines: what US travelers should know

Valneva travel vaccines protect against infections like cholera and Japanese encephalitis for people heading to higher-risk regions. Here is how they work, who they are for, and what US travelers should discuss with their doctors.

Valneva travel vaccines target infections that travelers risk when visiting certain regions, offering prevention options for diseases such as cholera and Japanese encephalitis. According to Valneva, it markets vaccines for travelers and endemic populations in more than 58 countries worldwideValneva, 03/2025, and this portfolio is often discussed in US travel medicine guidanceCDC, 01/2025.

Updated: 05/17/2026 | Reading time: approx. 9 minutes

By the AD HOC NEWS editorial team - specialized in product-led market coverage.

At a Glance

• Product: Valneva travel vaccines
• Category: Travel and endemic disease vaccines
• Brand/Manufacturer: Valneva SE
• Main Use Cases: Immunization of travelers and at-risk adults
• Key Markets: Europe, North America, Asia-Pacific

What Valneva travel vaccines are and how they work

Valneva travel vaccines are a group of prescription vaccines designed to help prevent specific infectious diseases in travelers and people living in endemic regions. The company positions itself as a specialty vaccine developer focusing on travel and infectious diseasesValneva, 03/2025.

Within this portfolio, Valneva highlights vaccines for diseases such as cholera, Japanese encephalitis, and chikungunya, as well as regional products for typhoid and other infections. These vaccines rely on immune system priming, where antigens or weakened pathogens train the body to recognize and respond to specific threatsValneva, 03/2025.

In modern travel vaccination, products are developed to meet regulatory standards for safety, quality, and effectiveness set by regional health authorities such as the European Medicines Agency and the US Food and Drug Administration, which evaluate data from clinical trials before approvalFDA, 02/2025.

Why Valneva travel vaccines matter for consumers and industry

For consumers, especially US residents planning trips to Asia, Africa, or parts of Latin America, travel vaccines play a role in preventing infections that routine childhood or adult vaccines in the United States do not always cover. The US Centers for Disease Control and Prevention recommends that travelers review destination-specific vaccine advice before departureCDC, 01/2025.

For the vaccine industry, products like Valneva travel vaccines fill a niche where diseases may be rare in the US but more common abroad. Specialty travel vaccines can support global health strategies by reducing infection risk among visitors and, indirectly, decreasing the chance that imported cases reach health systems at homeWHO, 05/2024.

Travel-focused vaccines are also part of broader preparedness efforts. Global health organizations emphasize that controlling diseases such as cholera and mosquito-borne infections requires a mix of vaccines, sanitation, and vector control, and travel vaccination is one tool that supports this combined approachWHO, 06/2024.

Valneva travel vaccines in the US and global market

Valneva presents itself as a global company headquartered in Europe that supplies vaccines to markets in North America, Asia-Pacific, and other regions, focusing on travelers and populations in endemic areasValneva, 03/2025. In the US, travel clinics and physicians rely on guidance from the CDC when deciding which vaccines to use or recommendCDC, 01/2025.

Vaccines targeting diseases associated with travel, such as cholera and Japanese encephalitis, are part of a global market where multiple manufacturers may offer different formulations that must meet regulatory standards set by authorities like the FDA and EMAFDA, 02/2025.

Travel vaccination demand often reflects trends in tourism, business travel, and international study programs. Health agencies highlight that even short trips can expose travelers to infections, and they recommend consulting healthcare providers several weeks before departure to plan vaccinations and other preventive stepsCDC, 01/2025.

• Travel vaccines are tailored to specific destinations and risks.
• Valneva focuses on diseases relevant to travelers and endemic regions.
• US travelers should seek medical advice early before trips.
• Regulators such as the FDA and EMA review vaccine data before approval.

Frequently Asked Questions about Valneva travel vaccines

Are Valneva travel vaccines available in the United States?
Travel vaccines are prescribed in the US according to FDA approvals and CDC guidance. Travelers should ask clinics which specific brands they use and follow CDC destination recommendationsCDC, 01/2025.

When should US travelers plan travel vaccinations?
The CDC advises seeing a healthcare provider ideally at least one month before traveling so that required vaccines can be administered and have time to take effect before departureCDC, 01/2025.

Do travel vaccines replace routine US vaccinations?
No. Health agencies explain that travel vaccines complement, but do not replace, routine childhood and adult immunizations recommended in the United StatesCDC, 02/2025.

Valneva SE is the biopharmaceutical company behind Valneva travel vaccines, with operations that include research, manufacturing, and commercialization of vaccines for travelers and endemic disease settingsValneva, 03/2025.

Valneva shares are listed in Europe, and the company has the ISIN FR0013280286 according to its investor relations informationValneva, 03/2025.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.